Romano Brothers & Co’s Integra LifeSciences IART Stock Holding History

Romano Brothers & Co’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-8,980	Closed	-$204K	–	304
2024 Q4	$204K	Buy	+8,980	New	+$196K	0.03%	298
2024 Q3	–	Sell	-11,614	Closed	-$338K	–	313
2024 Q2	$338K	Hold	11,614	–	–	0.05%	241
2024 Q1	$412K	Hold	11,614	–	–	0.06%	224
2023 Q4	$506K	Hold	11,614	–	–	0.08%	195
2023 Q3	$444K	Hold	11,614	–	–	0.07%	208
2023 Q2	$478K	Sell	11,614 -600	-5%	-$28.9K	0.07%	211
2023 Q1	$701K	Hold	12,214	–	–	0.11%	174
2022 Q4	$685K	Hold	12,214	–	–	0.1%	169
2022 Q3	$517K	Buy	+12,214	New	+$626K	0.08%	197

Other funds holding IART

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Romano Brothers & Co's IART Position: Q1 2025 in Review

Romano Brothers & Co sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 8,980 shares — an estimated $204K sold.

Romano Brothers & Co first reported a position in IART in Q3 2022 and held it in 9 quarters. The position peaked at $701K in Q1 2023. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

Romano Brothers & Co reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
Romano Brothers & Co sold 8,980 Integra LifeSciences shares in Q1 2025, an estimated $204K.
Romano Brothers & Co first reported a position in Integra LifeSciences in Q3 2022 and held it in 9 quarters.
Romano Brothers & Co's Integra LifeSciences position peaked at $701K in Q1 2023.
219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Romano Brothers & Co's 13F filing for Q1 2025, filed 10 Apr 2025.